Skip to main content
Bengisu Akbil on Muck Rack

Bengisu Akbil

As seen in: BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bengisu

Contact Bengisu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Synergistic latency reversal by the IAP antagonist AZD5582 and BET inhibitor JQ1, combined with Nef ablation, facilitates immune-mediated elimination of latently HIV-1-infected T-cells

|
By Dylan Postmus, Bengisu Akbil, Sui Ting Hui
| BioRxiv
Abstract The "shock-and-kill" strategy can reactivate latent HIV-1 in vivo but has failed to meaningfully reduce the reactivatable reservoir, suggesting insufficient immunological visibility of infected cells.
Open in Who Shared Issue with article?

Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1

|
By Christian Meisel, Tim Meyer, Erwin Lankes, Bengisu Akbil
| The Journal of Clinical Investigation
Concise CommunicationCOVID-19Immunology Free access | 10.1172/JCI150867 Christian Meisel,1,2 Bengisu Akbil,3,4 Tim Meyer,1 Erwin Lankes,5 Victor M. Corman,3,4 Olga Staudacher,1,4,6,7 Nadine Unterwalder,1 Uwe Kölsch,1 Christian Drosten,3,4 Marcus A. Mall,4,6,8 Tilmann Kallinich,4,6,9 Dirk Schnabel,5 Christine Goffinet,3,4 and Horst von Bernuth1,4,6,7 1Department of Immunology, Labor Berlin GmbH, Berlin, Germany.
Open in Who Shared Issue with article?
See all 2 articles